Endoso

Shenzhen, China Founded: 2020 • Age: 6 yrs
Disposable electronic microscopes and consumables are manufactured in Shenzhen, China.

About Endoso

Endoso is a Healthcare company based in Shenzhen (China) founded in 2020. Disposable electronic microscopes and consumables are manufactured in Shenzhen, China. Endoso has raised $14 million across 2 funding rounds from investors including Shandong Weigao Group Medical Polymers and BGI Co-win. Endoso offers products and services including Optical Hard Mirror and Disposable Electronic Endoscope. Its focus areas include Traditional Medical Devices. Its legal entity in India is ζ­ε·žθ‹±ζœ―η”Ÿε‘½η§‘ζŠ€ζœ‰ι™ε…¬εΈ (U99999MH1977PLC010754).

Company details

Endoso was established in 2020 in Shenzhen, China, where manufacturing operations for disposable electronic microscopes and related consumables are conducted. The company operates within the medical devices sector, focusing on single-use products designed for laboratory and clinical applications. Production emphasizes efficiency and compliance with industry standards. The website endoso.com.cn serves as the primary online presence for company details and inquiries.

  • Headquarters Shenzhen, China
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website endoso.com.cn
  • Legal Name 杭州英术生命科技有限公司
  • Date of Incorporation 10 Aug, 1977
  • Jurisdiction Maharashtra, India
Key Metrics

Products & Services of Endoso

Endoso offers a comprehensive portfolio of products and services, including Optical Hard Mirror and Disposable Electronic Endoscope.

Optical Hard Mirror
Medical Devices

Optical hard mirrors are manufactured for use in endoscopic procedures to enhance visibility during medical examinations.

Disposable Electronic Endoscope
Medical Devices

Disposable electronic endoscopes are provided for single-use applications in surgical settings to ensure hygiene and efficiency.

Funding Insights of Endoso

Endoso has successfully raised a total of $14M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $14 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $14M
  • Total Rounds 2
  • Last Round Series A β€” $14M
  • Investors Count 2

All 2 funding rounds of Endoso with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2024$14MSeries A–Shandong Weigao Group Medical Polymers
–
Nov 2022Seed––
Valuation history

2 investors in total: 2 institutional.

Investors in Endoso

Endoso has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Shandong Weigao Group Medical Polymers and BGI Co-win.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
bgi-cowin.com
Provider of integrated medical device solutions
1988weigaogroup.comWeihai, China
Premium access

Investor details for Endoso

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Endoso

3 dated milestones of Endoso across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Endoso is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series A, of $14.0M.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Endoso

Premium access

Complete news archive for Endoso

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Endoso

Endoso was founded in 2020 and raised its 1st funding round 2 years after it was founded.

Endoso is headquartered in Shenzhen, China. It is registered at Shenzhen, Guangdong, China.

Endoso is a funded company, having raised a total of $14M across 2 funding rounds to date.

Endoso was established in 2020 in Shenzhen, China, where manufacturing operations for disposable electronic microscopes and related consumables are conducted. The company operates within the medical devices sector, focusing on single-use products designed for laboratory and clinical applications. Production emphasizes efficiency and compliance with industry standards. The website endoso.com.cn serves as the primary online presence for company details and inquiries.

Endoso offers Optical Hard Mirror and Disposable Electronic Endoscope.

Endoso has 2 investors. Key investors include Shandong Weigao Group Medical Polymers, and BGI Co-win.

Endoso operates through ,.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available